These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34993675)

  • 21. Cost-effectiveness of endovascular thrombectomy in patients with acute stroke and M2 occlusion.
    Khunte M; Wu X; Payabvash S; Zhu C; Matouk C; Schindler J; Sanelli P; Gandhi D; Malhotra A
    J Neurointerv Surg; 2021 Sep; 13(9):784-789. PubMed ID: 33077578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of tissue-type plasminogen activator in the 3- to 4.5-hour time window for acute ischemic stroke.
    Tung CE; Win SS; Lansberg MG
    Stroke; 2011 Aug; 42(8):2257-62. PubMed ID: 21719767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantified health and cost effects of faster endovascular treatment for large vessel ischemic stroke patients in the Netherlands.
    van Voorst H; Kunz WG; van den Berg LA; Kappelhof M; Pinckaers FME; Goyal M; Hunink MGM; Emmer BJ; Mulder MJHL; Dippel DWJ; Coutinho JM; Marquering HA; Boogaarts HD; van der Lugt A; van Zwam WH; Roos YBWEM; Buskens E; Dijkgraaf MGW; Majoie CBLM;
    J Neurointerv Surg; 2021 Dec; 13(12):1099-1105. PubMed ID: 33479037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Cost-Effectiveness of Severity-Based Triaging for Large Vessel Occlusion Stroke.
    Gao L; Moodie M; Yassi N; Davis SM; Bladin CF; Smith K; Bernard S; Stephenson M; Churilov L; Campbell BCV; Zhao H
    Front Neurol; 2022; 13():871999. PubMed ID: 35645977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Review of the Cost and Cost-Effectiveness of Rapid Endovascular Therapy for Acute Ischemic Stroke.
    Sevick LK; Ghali S; Hill MD; Danthurebandara V; Lorenzetti DL; Noseworthy T; Spackman E; Clement F
    Stroke; 2017 Sep; 48(9):2519-2526. PubMed ID: 28716983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-Effectiveness of KTE-X19 for Adults with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia in the United States.
    Shah BD; Smith NJ; Feng C; Jeyakumar S; Castaigne JG; Faghmous I; Masouleh BK; Malone DC; Bishop MR
    Adv Ther; 2022 Aug; 39(8):3678-3695. PubMed ID: 35727476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-Effectiveness of Coronary and Peripheral Artery Disease Antithrombotic Treatments in Finland.
    Soini E; Virtanen O; Väätäinen S; Briere JB; Bowrin K; Millier A
    Adv Ther; 2020 Jul; 37(7):3348-3369. PubMed ID: 32519113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Cost-Utility Analysis of Endovascular Thrombectomy in a Real-World Setting.
    Koto PS; Hu SX; Virani K; Simpkin WL; Christian CA; Cao H; Shankar JJS; Phillips SJ
    Can J Neurol Sci; 2020 Jan; 47(1):50-60. PubMed ID: 31587672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of edaravone dexborneol versus edaravone for the treatment of acute ischemic stroke in China: Based on the TASTE study.
    Shi F; He Z; Wang L; Su H; Han S
    Front Pharmacol; 2022; 13():938239. PubMed ID: 36330098
    [No Abstract]   [Full Text] [Related]  

  • 31. Real-World Cost-Effectiveness of Late Time Window Thrombectomy for Patients With Ischemic Stroke.
    Gao L; Bivard A; Parsons M; Spratt NJ; Levi C; Butcher K; Kleinig T; Yan B; Dong Q; Cheng X; Lou M; Yin C; Chen C; Wang P; Lin L; Choi P; Miteff F; Moodie M
    Front Neurol; 2021; 12():780894. PubMed ID: 34970213
    [No Abstract]   [Full Text] [Related]  

  • 32. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
    Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative Effectiveness of Endovascular Thrombectomy in Elderly Stroke Patients.
    Malhotra A; Wu X; Payabvash S; Matouk CC; Forman HP; Gandhi D; Sanelli P; Schindler J
    Stroke; 2019 Apr; 50(4):963-969. PubMed ID: 30908156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-Utility Analysis of the Integrated Care Models for the Management of Hypertension Patients: A Quasi-Experiment in Southwest Rural China.
    Ke X; Zhang L; Tang W
    Front Public Health; 2021; 9():727829. PubMed ID: 34966712
    [No Abstract]   [Full Text] [Related]  

  • 35. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
    Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Cost-Effectiveness of Mechanical Thrombectomy Beyond 6 Hours Following Advanced Imaging in the United Kingdom.
    Peultier AC; Redekop WK; Allen M; Peters J; Eker OF; Severens JL
    Stroke; 2019 Nov; 50(11):3220-3227. PubMed ID: 31637975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of CYP2C19 genotyping to guide antiplatelet therapy for acute minor stroke and high-risk transient ischemic attack.
    Cai Z; Cai D; Wang R; Wang H; Yu Z; Gao F; Liu Y; Kang Y; Wu Z
    Sci Rep; 2021 Apr; 11(1):7383. PubMed ID: 33795788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective.
    Arora N; Makino K; Tilden D; Lobotesis K; Mitchell P; Gillespie J
    J Med Econ; 2018 Aug; 21(8):799-809. PubMed ID: 29741126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.